三星医疗：第六届董事会第二十七次会议决议公告

Group 1 - The core point of the article is that Samsung Medical has announced the approval of a proposal regarding expected daily related transactions for the year 2026 during its board meeting [2] - The proposal was passed with the recusal of related directors Shen Guoying, Zheng Jianjiang, and Lv Meng from the voting process [2] - The proposal has also been approved by a special meeting of independent directors [2]